NCT07246863 2026-03-04
Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC
CatalYm GmbH
Phase 2 Recruiting
CatalYm GmbH
Compugen Ltd
Rigshospitalet, Denmark
Rush University Medical Center
The Canadian College of Naturopathic Medicine
Tam Anh Research Institute